Lilly Pauses COVID-19 Antibody Trial

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has paused its trial of an antibody treatment for COVID-19. While a specific reason for the pause was not provided, the pharmaceutical company says the... Read More